<DOC>
	<DOCNO>NCT01509963</DOCNO>
	<brief_summary>The purpose study prospectively evaluate combine use MSKCC nomogram ( Memorial Sloan-Kettering Cancer Center ) Tenon score select , patient metastatic sentinel lymph node ( SN ) , low risk metastatic non-SN additional axillary lymph node dissection ( ALND ) could avoid .</brief_summary>
	<brief_title>The Memorial Sloan-Kettering Cancer Center ( MSKCC</brief_title>
	<detailed_description>EXPERIMENTAL PLAN AND COURSE OF STUDY This prospective non-randomized non-interventional multicenter study include respect quality charter involve prospective registration clinical histological data test hypothesis proportion false negative rate ( =rate metastatic SN ) 5 % +/- 5 % within population low risk combine use MSKCC nomogram Tenon score . No modification therapy conduct score provide operator . 6.1 Conduct study 6.1.1 Before surgery Every surgeon agree participate study - thus respect quality charter - make inclusion eligible patient e-CRF generate automatically number anonymity . A form inclusion specify number anonymity patient , initial name first name well date birth patient send back e-mail study coordinator clinical study technician ( CST ) URC-Est . The surgeon disposal 60 board label anonymity elaborate CST URC-Est correspond 30 patient ( 2 board labels patient ) . The resupplying label manage CST . A label contain ) number anonymity , ii ) address phone number surgeon , iii ) address phone number pathology laboratory , iv ) address phone number study coordinator include fax number pathological result send . During first intervention , surgeon send histological specimen ( i.e . lumpectomy mastectomy , SN , possibly non-SN case ALND complete first surgical procedure board label anonymity . In case additional surgical procedure complete ALND , histological specimen ( i.e . non-SN ) send pathology laboratory second board label anonymity correspond patient . The laboratory pathology label anonymity label histological report send study coordinator . To eventually calculate combine prediction ( MSKCC nomogram Tenon score ) ensure respect quality charter , specific data must appear pathology report : - Clinical information : age patient , location primitive tumor ( upper outer quadrant , SUPERO-medial , INFERO-lateral , INFERO-internal retroareolar ) , palpable tumor , result histological cytological diagnosis perform preoperatively . - Regarding number lumpectomy : size invasive cancer ( large diameter ) , histologic type , associate intra ductal carcinoma ( type percentage ) , existence vascular lymphatic embolus , estrogen receptor status , progesterone receptor status , HER-2-neu status , SCAFF Bloom-Richardson grade equivalent , realize , level expression antigen Ki 67 ; regard sentinel lymph node : number SN harvest ; metastatic SN : type metastasis : macrometastasis , micrometastasis , isolated cell , method intraoperative diagnosis metastasis ( perform ) : frozen section , cytology , RT-PCR . Final pathologic exam : routine H &amp; E , serial sectioning H &amp; E , IHC . Regarding non-sentinel lymph node : number non-SN - number metastatic non-SN , postoperative TNM . 6.1.2 Collection histological result pathology laboratories The study data inform pathology report . Ten week receive e-CRF , CST URC-EST responsibility study coordinator contact pathology laboratory . The latter label anonymity label histology report correspond first possibly , additional ALND do , fax report study coordinator ( fax number label ) . 6.2 Procedure calculate risk non-SN involvement A calculation probability metastatic non-SN use MSKCC nomogram Tenon score perform patient . Calculations implement responsibility coordinate doctor . The result calculation communicate surgeon . 6.2.1 Calculating score Tenon - Variable 1 : Existence macrometastasis non-SN : macrometastases , 2 point assign , 0 otherwise . - Variable 2 : histological size invasive tumor : 3 point tumor great 20 mm , 1.5 point size 10 20 mm 0 point less 10 mm . - Variable 3 : Ratio number metastatic SN ( whatever type metastasis ( macrometastasis , micrometastasis isolate tumor cell ) ) number SN harvest : 2 point ratio 1 ; 1 point 0.5 1 , 0 point less 0.5 . The score 3 variable add together calculate score Tenon . 6.2.2 Calculation risk MSKCC nomogram This calculation involve 8 variable : 1 ) histological type associate SBR grade ( infiltrate ductal carcinoma grade 1 , grade 2 , grade 3 invasive lobular carcinoma ( ILC ) ) , 2 ) existence LYMPHO-vascular invasion ( LVI ) ( yes , ) , 3 ) multifocal nature tumor ( yes , ) , 4 ) status estrogen receptor ( present , absent ) , 4 ) number non-metastatic SN ( 0 14 ) , 5 ) number metastatic SN ( 1 7 ) , 6 ) size tumor ( 0 9 cm ) , 7 ) method detect metastasis SN . For latter , 2 different situation : use technique CRYOCONGELATION , 4 item propose ( CRYOCONGELATION analysis , analysis H &amp; E : routine H &amp; E serial sectioning H &amp; E , IHC ) , absence use technology cryocongelation 3 item propose ( analysis H &amp; E : routine H &amp; E serial sectioning H &amp; E , IHC ) . 1 . The calculation must do use calculator develop author easily accessible website http : //www.mskcc.org/MSKCC/htlm/5794.cfm . - First Row `` Performed Frozen Section . The item must check pathologist perform frozen section intra-operatively . Otherwise , item must check . - Second line `` Pathological size ( cm ) '' must refer histological size large tumor diameter centimeter . - Third line `` Tumor type grade '' : must select correspond item 4 item offer : ductal I ( infiltrate ductal carcinoma ( TCC ) grade 1 ) , ductal II ( TCC grade 2 ) , ductal III ( TCC grade 3 ) lobular ( infiltrate lobular carcinoma ) . - Fourth line `` Number Positive Sentinel Lymph Nodes '' must report number metastatic SN , whatever type flooding ( macrometastasis micrometastasis isolate cell ) . - Fifth line `` SN Method Detection '' : must select item . Two scenario : 1 . In first line item `` Frozen Section Performed '' check : 4 item offer : Frozen ( metastasis diagnose frozen section ) . However , scenario produce case , patient receive ALND operation procedure SN ; Routine ( metastasis diagnose analyze routine H &amp; E ) , Serial ( metastasis diagnose serial sectioning H &amp; E ) , IHC ( metastasis diagnose IHC ) 2. first line item `` Frozen Section Performed '' check : 3 item propose : Routine ( metastasis diagnose analyze routine H &amp; E ) , Serial ( metastasis diagnose serial sectioning H &amp; E ) , IHC ( metastasis diagnose IHC ) . - Sixth row `` Number Negative Sentinel Lymph Nodes ' : number non-metastatic SN . - Seventh row `` Lymphovascular Invasion . '' The item must check case lymphatic vascular embolus . - Eighth row `` Multifocality . The item must check case multifocality . - Ninth Line `` Estrogen Receptor Positive '' . The item must check tumor estrogen receptor . 2 . The use nomogram ( defined graphical representation model ) recommend calculation less precise web interface . 6.2.3 Risk calculation combine MSKCC nomogram Tenon score - Group low risk metastatic non-SN : probability MSKCC nomogram ≤ 10 % score Tenon ≤ 3.5 . - Group risk metastatic non-SN : probability MSKCC nomogram &gt; 10 % and/or Tenon score &gt; 3.5 . 6.3 Monitoring patient include study The study evaluate combine use two predictor baseline . It require monitoring . However , patient monitor regularly breast cancer adjuvant treatment breast cancer remain unchanged study . 6.4 Total time research The recruitment opening study center plan period 6 month . Inclusion patient plan period 18 month . The total duration study 24 month .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Patients age 18 year old invasive breast cancer indication SN procedure recommend SaintPaul de VENCE 2005 amend 2009 T12 breast cancer Patients social security coverage . Patient age 18 . Patient neoadjuvant chemotherapy . Patient radiotherapy ipsilateral axilla breast . Pregnant patient . Patients speak French . Patients refuse participate study . Simultaneous participation another research period exclusion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>MSKCC nomogram</keyword>
	<keyword>Tenon score</keyword>
	<keyword>metastatic SN</keyword>
	<keyword>low risk metastatic non-SN</keyword>
	<keyword>additional ALND</keyword>
</DOC>